Market Value122,670,595
Total Holdings68
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
MLTX / MoonLake Immunotherapeutics
SRRK / Scholar Rock Holding Corporation
CADL / Candel Therapeutics, Inc.
EQT / EQT Corporation
KNSA / Kiniksa Pharmaceuticals, Ltd.
QDEL / QuidelOrtho Corporation
KPTI / Karyopharm Therapeutics Inc.
BLUE / bluebird bio, Inc.
ATRA / Atara Biotherapeutics, Inc.
LUNG / Pulmonx Corporation
ALMS / Alumis Inc.
PBAX / Phoenix Biotech Acquisition Corp.
ZBIO / Zenas BioPharma, Inc.
NPCE / NeuroPace, Inc.
QURE / uniQure N.V.
TMCI / Treace Medical Concepts, Inc.
ARVN / Arvinas, Inc.
GOSS / Gossamer Bio, Inc.
LQDA / Liquidia Corporation
CSTL / Castle Biosciences, Inc.
AXSM / Axsome Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
INBX / Inhibrx Biosciences, Inc.
TELA / TELA Bio, Inc.
OM / Outset Medical, Inc.
NVCR / NovoCure Limited
IFRX / InflaRx N.V.
UTHR / United Therapeutics Corporation
BDSX / Biodesix, Inc.
WVE / Wave Life Sciences Ltd.
FHTX / Foghorn Therapeutics Inc.
ELUT / Elutia Inc.
CYTK / Cytokinetics, Incorporated
PRTA / Prothena Corporation plc
TSVT / 2seventy bio, Inc.
BPMC / Blueprint Medicines Corporation
PGNY / Progyny, Inc.
XENE / Xenon Pharmaceuticals Inc.
SWTX / SpringWorks Therapeutics, Inc.
TXG / 10x Genomics, Inc.
MASI / Masimo Corporation
STOK / Stoke Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
NBIX / Neurocrine Biosciences, Inc.
KALV / KalVista Pharmaceuticals, Inc.
AXGN / Axogen, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
CABA / Cabaletta Bio, Inc.
HALO / Halozyme Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
PHR / Phreesia, Inc.
ATEC / Alphatec Holdings, Inc.
HROW / Harrow, Inc.
BHVN / Biohaven Ltd.
AXDX / Accelerate Diagnostics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
XNCR / Xencor, Inc.
CGEM / Cullinan Therapeutics, Inc.
CHRS / Coherus Oncology, Inc.
KROS / Keros Therapeutics, Inc.
CORT / Corcept Therapeutics Incorporated
PTGX / Protagonist Therapeutics, Inc.
OVV / Ovintiv Inc.
ALKS / Alkermes plc
VTYX / Ventyx Biosciences, Inc.
FOLD / Amicus Therapeutics, Inc.
DCGO / DocGo Inc.
BMY / Bristol-Myers Squibb Company
TECL / Direxion Shares ETF Trust - Direxion Daily Technology Bull 3X Shares